ubamatamab
regeneron
['ubamata', 'ovarian']
ubamatamab, a muc16xcd3 bispecific ab proves clinical activity in heavily pretreated ovarian cancer pts. responses greater in muc2 higher expressing pts. possibly a new target and a new therapeutic option. eagerly awaiting phase ii #esmo 
??????????? ??? ????????. Passionate and perfectionist. Med Onc with special love to Gyn Onc and prostate cancer.